2 Reasons Pfizer's COVID Vaccine Prospects Just Got Even Better

2 Reasons Pfizer's COVID Vaccine Prospects Just Got Even Better
Keith Speights, The Motley Fool
·3 min read

It's the exact opposite of Murphy's law (the name is "Murphy" spelled backward). Pfizer (NYSE: PFE) seems to be experiencing the effects of Yhprum's law with the COVID-19 vaccine it developed and marketed with BioNTech (NASDAQ: BNTX). Pfizer and BioNTech have delivered nothing but good news for their COVID-19 vaccine Comirnaty (BNT162b2) so far.